Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Overkamp

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Onkologie|April 18, 2009
Bortezomib in relapsed multiple myeloma: results of a non-interventional study by office-based haematologistsWolfgang Ulrich Knauf, Burkhard Otremba, Friedrich Overkamp, et al.
Breast Cancer Research and Treatment|October 21, 2010
Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patientsMathias Warm, Ronald Kates, Friedrich Overkamp, et al.
Anticancer Research|June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and TreatmentChristian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
BMC Cancer|July 27, 2017
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)Thomas Decker, Friedrich Overkamp, Siegfried Rösel, et al.
Current Opinion in Obstetrics & Gynecology|December 7, 2018
Translational highlights in breast cancer research and treatment: recent developments with clinical impactPeter A Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, et al.
Breast Care (Basel, Switzerland)|March 5, 2011
Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Christian Jackisch, Michael Untch, Dimitrios Chatsiproios, et al.
BMC Cancer|February 25, 2026
ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancerStephan W Sahm, Ulf Peter Neumann, Mark-Oliver Zahn, et al.
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Onkologie|March 15, 2013
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional studyLothar Bergmann, Peter J Goebell, Ulrich Kube, et al.
Geburtshilfe Und Frauenheilkunde|March 19, 2019
Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical PracticeWolfgang Janni, Andreas Schneeweiss, Volkmar Müller, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Onkologie|April 18, 2009
Bortezomib in relapsed multiple myeloma: results of a non-interventional study by office-based haematologistsWolfgang Ulrich Knauf, Burkhard Otremba, Friedrich Overkamp, et al.
Breast Cancer Research and Treatment|October 21, 2010
Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patientsMathias Warm, Ronald Kates, Friedrich Overkamp, et al.
Anticancer Research|June 9, 2016
Management of Metastatic Bone Disease Algorithms for Diagnostics and TreatmentChristian F Jehn, Ingo J Diel, Friedrich Overkamp, et al.
BMC Cancer|July 27, 2017
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)Thomas Decker, Friedrich Overkamp, Siegfried Rösel, et al.
Current Opinion in Obstetrics & Gynecology|December 7, 2018
Translational highlights in breast cancer research and treatment: recent developments with clinical impactPeter A Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, et al.
Breast Care (Basel, Switzerland)|March 5, 2011
Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Christian Jackisch, Michael Untch, Dimitrios Chatsiproios, et al.
BMC Cancer|February 25, 2026
ERBITAG: Non-interventional study on the efficacy of cetuximab in first-line therapy in patients with RAS wild-type metastatic colorectal cancerStephan W Sahm, Ulf Peter Neumann, Mark-Oliver Zahn, et al.
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Onkologie|March 15, 2013
Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional studyLothar Bergmann, Peter J Goebell, Ulrich Kube, et al.
Geburtshilfe Und Frauenheilkunde|March 19, 2019
Update Breast Cancer 2019 Part 2 - Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical PracticeWolfgang Janni, Andreas Schneeweiss, Volkmar Müller, et al.
Pageof 6